Pharmacovigilance of natural products for medicinal use

Abstract

The situation in Ecuador regarding the Pharmacovigilance of natural products for medicinal use is addressed, as well as the need to expand the scope of the national safety surveillance system for natural medicines, which, although they usually have wider therapeutic margins and they tend to produce fewer adverse effects than synthetic drugs, they have side effects, which can be of an adverse reaction. It summarizes how to develop a Pharmacovigilance Plan for these products and reviews the roles and responsibilities of pharmaceutical laboratories that manufacture natural medicines according to the guidelines of Good Pharmacovigilance Practices.